Literature DB >> 21390193

Use of carbon dioxide as negative contrast agent for magnetic resonance cholangiopancreatography.

Ching-Wen Chen1, Yi-Sheng Liu, Chiung-Yu Chen, Hong-Ming Tsai, Shu-Chen Chen, Ming-Tsung Chuang.   

Abstract

AIM: To evaluate the effects of using CO(2) as negative contrast agent in decreasing the overlapping on the pancreaticobiliary system from intestinal fluids.
METHODS: We evaluated the magnetic resonance cholangiopancreatography (MRCP) images in 117 patients divided into two groups (group 1, without taking gas producing crystals to produce CO(2), n = 64; group 2, with CO(2), n = 53) in a 1.5T unit using MRCP sequence. Anatomic locations of intestinal fluids distribution, overlapping with common bile duct (CBD) and pancreatic duct (PD), were evaluated.
RESULTS: In the group with CO(2), the decrease in distribution of intestinal fluids was significant in the gastric antrum (P = 0.001) and duodenal bulb (P < 0.001), but not in the gastric fundus and body and in the second portion of the duodenum (P = 1.000, P = 0.171, and P = 0.584 respectively). In the group with CO(2), the decrease in overlapping with CBD was significant (P < 0.001), but the decrease in overlapping with PD was not (P = 0.106).
CONCLUSION: MRCP with carbon dioxide as negative contrast agent would decrease intestinal fluids in the gastric antrum and duodenal bulb, thereby decreasing overlapping with the CBD.

Entities:  

Keywords:  Carbon dioxide; Gas-producing crystals; Magnetic resonance cholangiopancreatography; Negative contrast medium

Year:  2011        PMID: 21390193      PMCID: PMC3051110          DOI: 10.4329/wjr.v3.i2.47

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  14 in total

Review 1.  Pitfalls in MR cholangiopancreatographic interpretation.

Authors:  H Irie; H Honda; T Kuroiwa; K Yoshimitsu; H Aibe; K Shinozaki; K Masuda
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

2.  Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography.

Authors:  Y L Chan; A C Chan; W W Lam; D W Lee; S S Chung; J J Sung; H S Cheung; A K Li; C Metreweli
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

3.  Current status of MR cholangiopancreatography.

Authors:  C Reinhold; P M Bret
Journal:  AJR Am J Roentgenol       Date:  1996-06       Impact factor: 3.959

4.  MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent.

Authors:  S Hirohashi; R Hirohashi; H Uchida; S Kitano; W Ono; H Ohishi; S Nakanishi
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

5.  MR cholangiopancreatography before and after oral blueberry juice administration.

Authors:  N Papanikolaou; A Karantanas; T Maris; N Gourtsoyiannis
Journal:  J Comput Assist Tomogr       Date:  2000 Mar-Apr       Impact factor: 1.826

6.  Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects.

Authors:  A S Fulcher; M A Turner; G W Capps; A M Zfass; K M Baker
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

Review 7.  MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature.

Authors:  Koray Hekimoglu; Yucel Ustundag; Abdurrahim Dusak; Zuhal Erdem; Bulent Karademir; Selim Aydemir; Sadi Gundogdu
Journal:  J Dig Dis       Date:  2008-08       Impact factor: 2.325

8.  Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging.

Authors:  K Hiraishi; I Narabayashi; O Fujita; K Yamamoto; A Sagami; Y Hisada; Y Saika; I Adachi; H Hasegawa
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

9.  Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography.

Authors:  J A Soto; M A Barish; E K Yucel; D Siegenberg; J T Ferrucci; R Chuttani
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography.

Authors:  K Koito; T Namieno; T Ichimura; N Yama; M Hareyama; K Morita; M Nishi
Journal:  Radiology       Date:  1998-07       Impact factor: 11.105

View more
  3 in total

1.  Oral effervescent agent improving magnetic resonance cholangiopancreatography.

Authors:  Heon-Ju Kwon; Kyoung Won Kim; Kyung A Kang; Mi Sung Kim; So Yeon Kim; Taeyong Park; Jeongjin Lee
Journal:  Quant Imaging Med Surg       Date:  2022-09

2.  Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: A systematic review of the literature.

Authors:  Anne Frisch; Thula C Walter; Bernd Hamm; Timm Denecke
Journal:  Acta Radiol Open       Date:  2017-08-30

3.  Performance survey on a new standardized formula for oral signal suppression in MRCP.

Authors:  Anne Frisch; Thula C Walter; Christian Grieser; Dominik Geisel; Bernd Hamm; Timm Denecke
Journal:  Eur J Radiol Open       Date:  2017-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.